186 related articles for article (PubMed ID: 31583707)
21. Levels and values of inflammatory markers in patients with angina pectoris.
Yip HK; Wu CJ; Hang CL; Chang HW; Yang CH; Hsieh YK; Fang CY; Fu M; Yeh KH; Chen MC
Int Heart J; 2005 Jul; 46(4):571-81. PubMed ID: 16157948
[TBL] [Abstract][Full Text] [Related]
22. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results.
Prins RC; Rademacher BL; Mongoue-Tchokote S; Alumkal JJ; Graff JN; Eilers KM; Beer TM
Urol Oncol; 2012; 30(1):33-7. PubMed ID: 20207556
[TBL] [Abstract][Full Text] [Related]
24. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
[TBL] [Abstract][Full Text] [Related]
25. High-sensitivity C-reactive protein, but not white blood cell count, independently predicted incident diabetes in a Japanese health screening population.
Oda E
Acta Diabetol; 2015 Oct; 52(5):983-90. PubMed ID: 26159115
[TBL] [Abstract][Full Text] [Related]
26. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
Sollie S; Michaud DS; Sarker D; Karagiannis SN; Josephs DH; Hammar N; Santaolalla A; Walldius G; Garmo H; Holmberg L; Jungner I; Van Hemelrijck M
BMC Cancer; 2019 Aug; 19(1):858. PubMed ID: 31464604
[TBL] [Abstract][Full Text] [Related]
27. White Blood Cell Count and C-Reactive Protein Independently Predicted Incident Diabetes: Yuport Medical Checkup Center Study.
Kashima S; Inoue K; Matsumoto M; Akimoto K
Endocr Res; 2019 Nov; 44(4):127-137. PubMed ID: 30895902
[No Abstract] [Full Text] [Related]
28. Markers of inflammation in relation to long-term cardiovascular mortality in patients with lower-extremity peripheral arterial disease.
Urbonaviciene G; Frystyk J; Flyvbjerg A; Urbonavicius S; Henneberg EW; Lindholt JS
Int J Cardiol; 2012 Oct; 160(2):89-94. PubMed ID: 21463908
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
Liu ZQ; Chu L; Fang JM; Zhang X; Zhao HX; Chen YJ; Xu Q
Asian J Androl; 2014; 16(3):467-71. PubMed ID: 24589465
[TBL] [Abstract][Full Text] [Related]
30. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
Song M; Liu T; Liu H; Zhang Q; Zhang Q; Wang Y; Ma X; Cao L; Shi H
BMC Cancer; 2022 Aug; 22(1):853. PubMed ID: 35927639
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.
Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
Int J Cardiol; 2019 Sep; 290():106-112. PubMed ID: 31104823
[TBL] [Abstract][Full Text] [Related]
32. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
[TBL] [Abstract][Full Text] [Related]
33. High-sensitivity C-reactive protein is an independent risk factor for non-vertebral fractures in women and men: The Tromsø Study.
Dahl K; Ahmed LA; Joakimsen RM; Jørgensen L; Eggen AE; Eriksen EF; Bjørnerem Å
Bone; 2015 Mar; 72():65-70. PubMed ID: 25460573
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein and incident hypertension in a worksite population of Japanese men.
Kansui Y; Matsumura K; Morinaga Y; Inoue M; Kiyohara K; Ohta Y; Goto K; Ohtsubo T; Ooboshi H; Kitazono T
J Clin Hypertens (Greenwich); 2019 Apr; 21(4):524-532. PubMed ID: 30834690
[TBL] [Abstract][Full Text] [Related]
35. Cross-sectional association between exposure to particulate matter and inflammatory markers in the Japanese general population: NIPPON DATA2010.
Michikawa T; Okamura T; Nitta H; Nishiwaki Y; Takebayashi T; Ueda K; Kadota A; Fujiyoshi A; Ohkubo T; Ueshima H; Okayama A; Miura K;
Environ Pollut; 2016 Jun; 213():460-467. PubMed ID: 26967353
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
38. A prospective follow-up study of the relationship between high-sensitivity C-reactive protein and primary liver cancer.
Siyin ST; Liu T; Li W; Yao N; Xu G; Qu J; Chen Y
BMC Cancer; 2020 Nov; 20(1):1168. PubMed ID: 33256656
[TBL] [Abstract][Full Text] [Related]
39. Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.
Zuo H; Tell GS; Vollset SE; Ueland PM; Nygård O; Midttun Ø; Meyer K; Ulvik A; Eussen SJ
Cancer; 2014 Nov; 120(21):3370-7. PubMed ID: 24948355
[TBL] [Abstract][Full Text] [Related]
40. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
